| Application no. and date | 15156024.0 (espacenet) (Federated) (European Patent Register), 20120918 | | Patent/reg. no. and date | DK/EP 2915525, 20210811 | | Publication date | 20150909 | | Priority no. and date | US 201161536180 P, 20110919 | | EP pub. no. and date |
EP 2915525 20150909 | | Effective date | | | Applicant/owner | Orexo AB, Box 303
751 05 Uppsala, SE | | Applicant ref. no. | OREQ/P51901EPdiv1 | | Inventor | Fischer, Andreas, Orexo AB
Box 303
SE-751 05 Uppsala, SE | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/4748 (2006.01) , A61K 31/485 (2006.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) , A61P 25/04 (2006.01) , A61P 25/30 (2006.01) , A61P 25/36 (2006.01) | | Title | Sublingual abuse-resistant tablets comprising buprenorphine and naloxone | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
